Real patient story
Meaningful story. Meaningful hope.
Hear the experience of an individual living with advanced NSCLC, a type of cancer that starts in the lungs. Learn about her personal journey with advanced NSCLC and her experience with LIBTAYO.
LIBTAYO is a prescription medicine used to treat adults with a type of lung cancer called non–small cell lung cancer (NSCLC). It may be used alone as your first treatment when your lung cancer has not spread outside your chest (locally advanced lung cancer) and you cannot have surgery or chemotherapy with radiation, or your cancer has spread to other areas of your body (metastatic lung cancer), and your tumor tests positive for high “PD-L1,” and you test negative for abnormal “EGFR,” “ALK,” or “ROS1” genes.
Individual results may vary.
Rose’s story
Play the video below to see her story.
Actual LIBTAYO patient who received LIBTAYO alone. Individual results may vary.
"At first I was scared, but I knew if I didn’t give it a shot, I would be a quitter, and I’m not a quitter. ...I was tired. I wanted to walk away, but I never missed an appointment."
Rose shares her story about living with locally advanced NSCLC (lung cancer that has not spread outside your chest). Listen as she takes you through her journey, from initial diagnosis, thoughtful conversations with her doctor, and her treatment experience with LIBTAYO.